LeonaBio, Inc. (LONA)
NGS · Common · CUSIP 04746L104
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for LONA and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
04746L104
Market Cap
Mid Cap
IPO
9/18/2020 · $17.00/share
Previous Symbol
ATHA (changed 1/8/2026)
Previous Name
Athira Pharma, Inc.
Business: Athira Pharma, Inc. is a clinical-stage biopharmaceutical company dedicated to the development of novel therapeutics for high unmet medical needs, including treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis.

Company Contact

CEO
Mark Litton
CFO
Robert Renninger
Headquarters
18706 North Creek Parkway, Suite 104, Bothell, WA 98011
Phone
425-620-8501
Investor Relations
Julie Rathbun · 206-769-9219 · Julie.rathbun@leonabio.com
SEC EDGAR Filings
View filings »